A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 57, Issue 5, 2016, Pages 633-644

  Janssen, Tieme W P ^a   Bink, Marleen ^a   Geladé, Katleen ^a,b   Van Mourik, Rosa ^c   Maras, Athanasios ^b   Oosterlaan, Jaap ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Yulius Academy ^*  (Netherlands)

^c ROYAL DUTCH KENTALIS   (Netherlands)

Author keywords

ADHD; EEG; methylphenidate; neurofeedback; physical activity; RCT

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; KINESIOTHERAPY; MALE; MULTICENTER STUDY; NEUROFEEDBACK; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN WAVES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOUBLE-BLIND METHOD; EXERCISE THERAPY; FEMALE; HUMANS; MALE; METHYLPHENIDATE; NEUROFEEDBACK; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84963808479     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/jcpp.12517     Document Type: Article

References (66)

1. Alderson, R., Rapport, M., &, Kofler, M., (2007). Attention-deficit/hyperactivity disorder and behavioral inhibition: A meta-analytic review of the stop-signal paradigm. Journal of Abnormal Child Psychology, 35, 745-758.
2. Arns, M., Conners, C.K., &, Kraemer, H.C., (2013). A decade of EEG Theta/Beta Ratio Research in ADHD: A meta-analysis. Journal of Attention Disorders, 17, 374-383.
3. Arns, M., de Ridder, S., &, Strehl, U., (2009). Efficacy of Neurofeedback Treatment in ADHD: The Effects on Inattention, Impulsivity and Hyperactivity: A Meta-Analysis. Clinical EEG and Neuroscience, 40, 180-189.
4. Arns, M., Heinrich, H., &, Strehl, U., (2014). Evaluation of neurofeedback in ADHD: The long and winding road. Biological Psychology, 95, 108-115. Elsevier B.V.
5. Arnsten, A.F.T., (2006). Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology, 31, 2376-2383.
6. Barkley, R.A., (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121, 65-94.
7. Barry, R.J., Clarke, A.R., Johnstone, S.J., Brown, C.R., Bruggemann, J.M., &, van Rijbroek, I., (2009). Caffeine effects on resting-state arousal in children. International Journal of Psychophysiology, 73, 355-361. Elsevier B.V.
8. Barry, R.J., Clarke, A.R., Johnstone, S.J., McCarthy, R., &, Selikowitz, M., (2009). Electroencephalogram theta/beta ratio and arousal in attention-deficit/hyperactivity disorder: Evidence of independent processes. Biological Psychiatry, 66, 398-401. Society of Biological Psychiatry.
9. Barry, R.J., Rushby, J.A., Wallace, M.J., Clarke, A.R., Johnstone, S.J., &, Zlojutro, I., (2005). Caffeine effects on resting-state arousal. Clinical Neurophysiology, 116, 2693-2700.
10. Bazanova, O.M., &, Vernon, D., (2013). Interpreting EEG alpha activity. Neuroscience and Biobehavioral Reviews, 44, 94-110. Elsevier Ltd.
11. Biederman, J., (2005 June 1). Attention-deficit/hyperactivity disorder: A selective overview. Biological Psychiatry, 57, 1215-1220.
12. Bink, M., van Nieuwenhuizen, C., Popma, A., Bongers, I.L., &, van Boxtel, G.J.M., (2015). Behavioral effects of neurofeedback in adolescents with ADHD: A randomized controlled trial. European Child & Adolescent Psychiatry, 24, 1035-1048. Springer Berlin Heidelberg.
13. Clarke, A.R., Barry, R.J., Bond, D., McCarthy, R., &, Selikowitz, M., (2002). Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl), 164, 277-284.
14. Clarke, A.R., Barry, R.J., McCarthy, R., &, Selikowitz, M., (2001). Age and sex effects in the EEG: Development of the normal child. Clinical Neurophysiology, 112, 806-814.
15. Clarke, A.R., Barry, R.J., McCarthy, R., &, Selikowitz, M., (2002). EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clinical Neurophysiology, 113, 194-205.
16. Clarke, A.R., Barry, R.J., McCarthy, R., Selikowitz, M., Brown, C.R., &, Croft, R.J., (2003). Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type. International Journal of Psychophysiology, 47, 129-137.
17. Coghill, D., Soutullo, C., d'Aubuisson, C., Preuss, U., Lindback, T., Silverberg, M., &, Buitelaar, J., (2008). Impact of attention-deficit/hyperactivity disorder on the patient and family: Results from a European survey. Child and Adolescent Psychiatry and Mental Health, 2, 31.
18. Dallal, G.E., (2007). Randomization plan generator; first generator. Available from: http://www.randomization.com [last accessed February 2010].
19. Duric, N.S., Assmus, J., Gundersen, D., &, Elgen, I.B., (2012 January). Neurofeedback for the treatment of children and adolescents with ADHD: A randomized and controlled clinical trial using parental reports. BMC Psychiatry, 12, 1-8.
20. Faraone, S.V., &, Buitelaar, J., (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child & Adolescent Psychiatry, 19, 353-364.
21. Faul, F., Erdefelder, E., Lang, A.G., &, Bunchner, A., (2007). G power 3: A flexible statistical power analysis program for the social, behavioral and biomedical sciences. Behavior Research Methods, 39, 175-191.
22. Geladé, K., Janssen, T.W.P., Bink, M., van Mourik, R., Maras, A., &, Oosterlaan, J., (in press). An RCT into the behavioural effects of neurofeedback compared to methylphenidate and physical activity in children with ADHD. Journal of Clinical Psychiatry.
23. Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P.,... &, Heinrich, H., (2009). Distinct EEG effects related to neurofeedback training in children with ADHD: A randomized controlled trial. International Journal of Psychophysiology, 74, 149-157.
24. Gevensleben, H., Rothenberger, A., Moll, G.H., &, Heinrich, H., (2012). Neurofeedback in children with ADHD: Validation and challenges. Expert Review of Neurotherapeutics, 12, 447-460.
25. Gevins, A.S., Zeitlin, G.M., Doyle, J.C., Yingling, C.D., Schaffer, R.E., Callaway, E., &, Yeager, C.L., (1979). Electroencephalogram correlates of higher cortical functions. Science, 203, 665-668.
26. Goncharova, I., McFarland, D., Vaughan, T., &, Wolpaw, J., (2003). EMG contamination of EEG: Spectral and topographical characteristics. Clinical Neurophysiology, 114, 1580-1593.
27. Graham, J., &, Coghill, D., (2008). Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: Epidemiology, prevention and management. CNS Drugs, 22, 213-237.
28. Gratton, G., Coles, M., &, Donchin, E., (1983). A new method for off-line removal of ocular artifact. Electroencephalography and Clinical Neurophysiology, 55, 468-484.
29. Greenhill, L.L., Abikoff, H.B., Arnold, L.E., Cantwell, D.P., Conners, K., Elliott, G.,... &, Wells, K., (1996). Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. Journal of American Academy of Child and Adolescent Psychiatry, 34, 1304-1313.
30. Greenhill, L.L., Halperin, J.M., &, Abikoff, H., (1999). Stimulant medications. Journal of American Academy of Child and Adolescent Psychiatry, 38, 503-512.
31. Halperin, J.M., Berwid, O.G., &, O'Neill, S., (2014). Healthy body, healthy mind?: The effectiveness of physical activity to treat ADHD in children. Child and Adolescent Psychiatric Clinics of North America, 23, 899-936.
32. Herrmann, C.S., &, Debener, S., (2008). Simultaneous recording of EEG and BOLD responses: A historical perspective. International Journal of Psychophysiology, 67, 161-168.
33. IBM Corp. (2011). IBM SPSS statistics for Windows. Armonk, NY: IBM Corp.
34. Janssen, T.W.P., Bink, M., Gelade, K., Mourik, R., Maras, A., &, Oosterlaan, J., (in press). A randomized controlled trial into the effects of neurofeedback, methylphenidate and physical activity on event-related potentials in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology.
35. Janssen, T.W.P., Heslenfeld, D.J., van Mourik, R., Gelade, K., Maras, A., &, Oosterlaan, J., (2015). Alterations in the ventral attention network during the stop-signal task in children With ADHD: An event-related potential source imaging study. Journal of Attention Disorders. Advanced online publication. doi: 10.1177/1087054715580847.
36. Kropotov, J.D., Grin-Yatsenko, V.A., Ponomarev, V.A., Chutko, L.S., Yakovenko, E.A., &, Nikishena, I.S., (2007). Changes in EEG spectrograms, event-related potentials and event-related desynchronization induced by relative beta training in ADHD children. Journal of Neurotherapy, 11, 3-11.
37. Lijffijt, M., Kenemans, J.L., Verbaten, M.N., &, van Engeland, H., (2005). A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: Deficient inhibitory motor control? Journal of Abnormal Psychology, 114, 216-222.
38. Logan, G., &, Cowan, W., (1984). On the ability to inhibit simple and choice reaction time responses: A theory of an act of control. Psychological Review, 91, 295-327.
39. Loo, S.K., &, Barkley, R.A., (2005). Clinical utility of EEG in attention deficit hyperactivity disorder. Applied Neuropsy-chology, 12, 64-76.
40. Loo, S.K., Cho, A., Hale, T.S., McGough, J., McCracken, J., &, Smalley, S.L., (2013). Characterization of the theta to beta ratio in ADHD: Identifying potential sources of heterogeneity. Journal of Attention Disorders, 17, 384-392.
41. Loo, S.K., Hopfer, C., Teale, P.D., &, Reite, M.L., (2004). EEG correlates of methylphenidate response in ADHD: Association with cognitive and behavioral measures. Journal of Clinical Neurophysiology, 21, 457-464.
42. Loo, S.K., &, Makeig, S., (2012). Clinical utility of EEG in attention-deficit/hyperactivity disorder: A research update. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 9, 569-587.
43. Loo, S.K., Teale, P., &, Reite, M., (1999). EEG correlates of psychostimulant effects among children with ADHD: A preliminary report. Biological Psychiatry, 45, 1657-1660.
44. Lubar, J.F., (1991). Discourse on the development of EEG diagnostics and biofeedback for attention-deficit/hyper-activity disorders. Biofeedback and Self-Regulation, 16, 201-225.
45. McMenamin, B.W., Shackman, A.J., Greischar, L.L., &, Davidson, R.J., (2011). Electromyogenic artifacts and electroencephalographic inferences revisited. NeuroImage, 54, 4-9. Elsevier Inc.
46. Meisel, V., Servera, M., Garcia-Banda, G., Cardo, E., &, Moreno, I., (2013). Neurofeedback and standard pharmacological intervention in ADHD: A randomized controlled trial with six-month follow-up. Biological Psychology, 94, 12-21. Elsevier B.V.
47. Monastra, V.J., Monastra, D.M., &, George, S., (2002). The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 27, 231-249.
48. Ogrim, G., &, Hestad, K.A., (2013). Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: A randomized pilot study. Journal of Child and Adolescent Psychopharmacology, 23, 448-457.
49. Ogrim, G., Kropotov, J., Brunner, J.F., Candrian, G., Sandvik, L., &, Hestad, K.A., (2014). Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: Data from quantitative electroencephalography, event-related potentials, and a go/no-go test. Neuropsychiatric Disease and Treatment, 10, 231-242.
50. Pelham, W.E., Gnagy, E.M., Greensalade, K.E., &, Milich, R., (1992). Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. Journal of American Academy of Child and Adolescent Psychiatry, 31, 210-218.
51. Rommel, A.-S., Halperin, J.M., Mill, J., Asherson, P., &, Kuntsi, J., (2013). Protection from genetic diathesis in attention-deficit/hyperactivity disorder: Possible complementary roles of exercise. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 900-910. Elsevier Inc.
52. Schlegelmilch, F., Markert, S., Berkes, S., &, Schellhorn, K., (2004). Online ocular artifact removal for dc-EEG-signals: Estimation of dc-level. Biomedizinische Technik, 2, 340-341.
53. Sergeant, J., (2000). The cognitive-energetic model: An empirical approach to attention-deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews, 24, 7-12.
54. Snyder, S.M., &, Hall, J.R., (2006). A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. Journal of Clinical Neurophysiology, 23, 440-455.
55. Snyder, S.M., Rugino, T.A., Hornig, M., &, Stein, M.A., (2015). Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior, 5, 1-17.
56. Song, D.H., Shin, D.W., Jon, D.I., &, Ha, E.H., (2005). Effects of methylphenidate on quantitative EEG of boys with attention-deficit hyperactivity disorder in continuous performance test. Yonsei Medical Journal, 46, 34-41.
57. Sonuga-Barke, E.J.S., Bitsakou, P., &, Thompson, M., (2010). Beyond the dual pathway model: Evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 345-355. Elsevier Inc.
58. Sonuga-Barke, E.J.S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M.,... & European ADHD Guidelines Group. (2013). Nonpharmacological Interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. The American Journal of Psychiatry, 170, 275-289.
59. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., &, Griffin, S., (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432. The American Academy of Child and Adolescent Psychiatry.
60. Swanson, J.M., Schuck, S., Mann, M., &, Carlson, C., (2006). Categorical and dimensional definitions and evaluations of symptoms of ADHD: The SNAP and SWAN rating scales. Irvine: University of California. Available from: http://www.adhd.net.
61. Swartwood, M.O., Swartwood, J.N., Lubar, J.F., Timmermann, D.L., Zimmerman, A.W., &, Muenchen, R.A., (1998). Methylphenidate effects on EEG, behavior, and performance in boys with ADHD. Pediatric Neurology, 18, 244-250.
62. Vasey, M.W., &, Thayer, J.F., (1987). The continuing problem of false positives in repeated measures ANOVA in psy-chophysiology: A multivariate solution. Psychophysiology, 24, 479-486.
63. Vázquez Marrufo, M., Vaquero, E., Cardoso, M.J., &, Gómez, C.M., (2001). Temporal evolution of α and β bands during visual spatial attention. Cognitive Brain Research, 12, 315-320.
64. Wechsler, D., (1991). Weschler intelligence scale for children, (3rd edn). San Antonio, TX: Psychological Corporation.
65. Willcutt, E.G., (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 9, 490-499.
66. Zentall, S., &, Zentall, T., (1983). Optimal stimulation: A model of disordered activity and performance in normal and deviant children. Psychological Bulletin, 94, 446-471.